Clearside Biomedical, Inc. (CLSD) Retained Earnings (Accumulated Deficit) USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Clearside Biomedical, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2015 to 2024.
  • Clearside Biomedical, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$333 M, a 11.7% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$333 M -$35 M -11.7% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$321 M -$32.5 M -11.3% Dec 31, 2023 10-Q 2024-05-10
Q3 2023 -$316 M -$37.3 M -13.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$307 M -$35.9 M -13.2% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$298 M -$34.6 M -13.1% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 -$288 M -$32.9 M -12.9% Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$279 M -$4.58 M -1.67% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 -$271 M -$1.64 M -0.61% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 -$263 M +$83 K +0.03% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 -$255 M +$376 K +0.15% Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$274 M -$25.4 M -10.2% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 -$269 M -$23 M -9.33% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 -$263 M -$22.7 M -9.42% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 -$256 M -$18.2 M -7.66% Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$249 M -$14.2 M -6.05% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 -$246 M -$18.3 M -8.02% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 -$241 M -$18.3 M -8.22% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 -$238 M -$30.8 M -14.9% Dec 31, 2019 10-K 2021-03-15
Q3 2019 -$235 M -$49.3 M -26.6% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 -$228 M -$66.7 M -41.3% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 -$222 M -$81.6 M -58% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 -$207 M -$82.7 M -66.5% Dec 31, 2018 10-K 2020-03-13
Q3 2018 -$185 M -$77.5 M -72% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 -$161 M -$72 M -80.5% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 -$141 M -$65 M -86% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 -$124 M -$59 M -90.4% Dec 31, 2017 10-K 2019-03-15
Q3 2017 -$108 M -$52.2 M -93.9% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 -$89.4 M -$39.5 M -79.1% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 -$75.6 M Mar 31, 2017 10-Q 2017-05-10
Q4 2016 -$65.2 M -$25.9 M -65.8% Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$55.6 M Sep 30, 2016 10-Q 2016-11-14
Q2 2016 -$49.9 M Jun 30, 2016 10-Q 2016-08-12
Q4 2015 -$39.4 M Dec 31, 2015 10-K 2017-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.